HHP Medication Safety Watch: October 2025

Harvard Health Publishing shares selected recalls, withdrawals, and alerts from the FDA, drug and supplement makers, and other sources. We’ve provided links to information for each product. Unless otherwise noted, these actions apply only to the specific brand name of the product listed. Talk to your health care provider before stopping or changing any medicines or treatments that they have recommended for you.

• Prescription medicines

Prescription medicines

Cholesterol-lowering drug recalled because tablets do not dissolve properly

• Atorvastatin, 10 mg, 20 mg, 40 mg, 80 mg tablets (maker: Aikem Laboratories)

Comment: More than 140,000 bottles of atorvastatin have been recalled by its maker because the tablets may not dissolve normally. If these tablets do not dissolve in the stomach as they should, the medication may be less effective.

Atorvastatin is among the most commonly prescribed medications in the world. It is generally prescribed to lower cholesterol, an important way to prevent and treat cardiovascular disease and its complications, such as heart attacks and stroke.

Blood pressure medicine recalled due to impurity

• Prazosin, 1 mg, 2 mg, and 5 mg capsules (maker: Teva Pharmaceuticals USA)

Comment: The maker of this medication has recalled more than 580,000 bottles due to detection of a nitrosamine, called N-nitroso Prazosin, in higher than acceptable levels. Nitrosamines are found at low levels in water and foods. However, exposure to higher than acceptable levels over time can potentially cause cancer.

Prazosin is most commonly prescribed for people with hypertension to lower their blood pressure. It is sometimes prescribed for other conditions, including nightmares related to post-traumatic stress disorder (PTSD), prostate enlargement, and Raynaud’s disease.

Read additional issues of HHP Medication Safety Watch